HLA & Allergy (HLA)

Project Number

Convenors


Co-ordination Committee chaired by Professor Mario Ricci (Istituto di Clinica Medica Generale e Terapia, Firenze, Italy)

Abstract


Human immune response has been studied from immunological disorders. Recombinant DNA technology has made possible the study of allergic response at the cellular and molecular level. This Network enables European laboratories to coordinate research into the role of HLA - Human Leukocyte Antigen - genes in the control of human response to allergens.

Duration


Three years, from June 1992 to June 1995 extended by ESF Executive Council decision to May 1996.

This network became an ESF à la carte scientific programme for a period of three years from January 1997 to end 1999.